Author:
Salem Ahmed M.,Harris Daniel,Bray Jonathan J.H.,Obaid Daniel R.,Stephens Jeffrey W.,Halcox Julian
Subject
Cardiology and Cardiovascular Medicine
Reference45 articles.
1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur. Heart J.,2020
2. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD diseases of the European Society of Cardiology (ESC) and the. 2020;Task,2019
3. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes;Eliaschewitz;N Engl J Med [Internet],2016
4. Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOMETM);Zinman;Cardiovasc Diabetol [Internet],2014
5. ESC/EAS Guidelines for the Management of Dyslipidaemias;Catapano;Eur Heart J,2016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献